Status:
TERMINATED
Analgesic Strategies in Newborns Receiving Prostaglandin Therapy
Lead Sponsor:
Nantes University Hospital
Conditions:
Pain
Eligibility:
All Genders
Up to 28 years
Phase:
NA
Brief Summary
This is a randomised trial comparing the efficacy of 3 different analgesic strategies in newborns on prostaglandin for ductus dependent congenital heart disease.
Eligibility Criteria
Inclusion
- Full-term newborn
- Under one month of age
- With ductus dependent congenital heart disease requiring prostaglandin infusion and elevated pain score
Exclusion
- Contraindication to either morphine, acetaminophen, or nalbuphine
- Other painful condition
- Poor neurological condition
- Cardiac instability requiring urgent surgery
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2006
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00200590
Start Date
December 1 2003
End Date
July 1 2006
Last Update
April 21 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nantes University Hospital
Nantes, France, 44093